JPRN-UMIN000002066尚未招募未知
Effect of alfha1-adrenoceptor antagonist in lower urinary tract symptoms after high dose brachytherapy for prostate cancer - Effect of alfha1-adrenoceptor antagonist in lower urinary tract symptoms after high dose brachytherapy for prostate cancer
Department of Urology,Kawasaki Medical School0 个研究点目标入组 100 人开始时间: 2009年6月15日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40years-old 至 ot applicable（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •1)Having an allergic history of silodosin 2)Having a neuropathic bladder or bladder neck sclerosis or urethral stricture or bladder stone,or sever bladder diverticulum 3)Having an Active urinary tract infection 4)Having a severe ischemic heart disease or cerebrovascular disorder or hepatic disease or renal disease 5)Judged sa being unsuitable for the trial by the doctor
研究者
相似试验
尚未招募
不适用
The effects of selective alpha-1-adrenergic receptor antagonists in patients with lower urinary tract symptoms caused by benign prostatic hyperplasiawho failed to obtain sufficient efficacy by previous alpha-1-blockades. . A comparison of Naftopidil or Silodosin.Benign Prostatic HyperplasiaJPRN-UMIN000003609Kansai Medical University Takii Hospital100
招募中
不适用
Effects of alpha1-adrenoceptor blocker on frequency/volume chart in treatment-naive patients with benign prostatic hyperplasia in the real-world clinical settingBenign prostatic hyperplasiaJPRN-UMIN000040755Hokkaido Prefectural Esashi Hospital100
招募中
2 期
Doxazosin to Prevent Severe COVID-19 (CALM-COVID Trial)CTRI/2021/09/036099Johns Hopkins University School of Medicine
已完成
不适用
The effect of alpha1-AR antagonists for lower urinary tract symptoms in patients undergoing prostate 125I brachytherapy for prostate carcinomaProstate cancerJPRN-UMIN000005786Kinki University Faculty of Medicine160
进行中（未招募）
不适用
Effect of selective alpha 1A receptor antagonists on the iris dilator muscleEffect of selective alpha 1A receptor antagonists on the iris dilator muscleEUCTR2015-003061-28-ATVienna Institute for Research in Ocular Surgery